Allergan Announces FDA Approval of Label Extensions for JUVEDERM Ultra and JUVEDERM Ultra Plus IRVINE, Calif. -- Allergan, Inc., the maker of BOTOX® Cosmetic (Botulinum Toxin Type A), today announced ...
IRVINE, Calif.--(BUSINESS WIRE)--Allergan, Inc. (NYSE:AGN), the maker of BOTOX(R) Cosmetic (Botulinum Toxin Type A), today announced it is launching its 'next-generation' hyaluronic acid dermal filler ...
Hyaluronic acid 24mg/mL; injectable gel implant. Should only be used by trained and experienced healthcare practitioners. Obtain patient's complete medical history prior to initiation. Avoid ...
IRVINE, Calif.--(BUSINESS WIRE)--Allergan, Inc. (NYSE:AGN), the maker of BOTOX ® Cosmetic (Botulinum Toxin Type A), today announced nationwide availability of its ‘next-generation’ hyaluronic acid ...
Juvéderm and Restylane are two types of dermal fillers used for the treatment of wrinkles. Both injections use a gel made with hyaluronic acid to plump up the skin. These are noninvasive procedures.
Belotero and Juvederm are both cosmetic fillers that are used to improve the appearance of wrinkles and restore facial contours for a more youthful appearance. Both are injectable dermal fillers with ...
Allergan Aesthetics Celebrates Third Annual JUVÉDERM® Day with BOGO Gift Cards and $10,000 Sweepstakes Join Allē Today to Take Advantage of Limited-Time Offers, While Supplies Last "JUVÉDERM® Day is ...
Co announces approval by the FDA of label extensions for JUVEDERM Ultra and JUVEDERM Ultra Plus based on new clinical data demonstrating that the effects of both products may last for up to one year, ...
Hyaluronic acid 24mg/mL; injectable gel implant. Should only be used by trained and experienced healthcare practitioners. Obtain patient's complete medical history prior to initiation. Avoid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback